Literature DB >> 26309706

A novel factor X gene mutation Val (GTC) 384Ala (GCC) in a Chinese family resulting in congenital factor X deficiency.

Yanming Wang1, Junjie Ma1, Xinguang Liu1, Yan Wang1, Hui Wang1, Li Wang1, Qiulan Ding2, Xiaoxia Chu1, Ming Hou3.   

Abstract

FX is a vitamin K-dependent coagulation protease critically essential for the coagulation cascade. FXD (congenital deficiency of factor X) is a rare coagulation disorder that inherited as an autosomal recessive trait. Here we reported a patient with bleeding diathesis from infant. The proband with pseudotumor in cerebral articular and cavity were identified as encapsulated hematocele ultimately. FX sequence analysis revealed that the patient carried a novel homozygous missense mutation that resulted in the Val384Ala substitution. Further investigation of the novel mutation would deepen our understanding of the bleeding mechanism involved in FXD.

Entities:  

Keywords:  FX deficiency; FXD; coagulation disorder; gene mutation

Year:  2015        PMID: 26309706      PMCID: PMC4538178     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

1.  Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis.

Authors:  M C de Visser; S R Poort; H L Vos; F R Rosendaal; R M Bertina
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

Review 2.  Inherited factor X deficiency: molecular genetics and pathophysiology.

Authors:  D N Cooper; D S Millar; A Wacey; S Pemberton; E G Tuddenham
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

3.  Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene.

Authors:  F H Herrmann; G Auerswald; A Ruiz-Saez; M Navarrete; H Pollmann; S Lopaciuk; A Batorova; K Wulff
Journal:  Haemophilia       Date:  2006-09       Impact factor: 4.287

4.  Molecular analysis of the genotype-phenotype relationship in factor X deficiency.

Authors:  D S Millar; L Elliston; P Deex; M Krawczak; A I Wacey; J Reynaud; H K Nieuwenhuis; P Bolton-Maggs; P M Mannucci; J C Reverter; P Cachia; K J Pasi; D M Layton; D N Cooper
Journal:  Hum Genet       Date:  2000-02       Impact factor: 4.132

5.  Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.

Authors:  M Dewerchin; Z Liang; L Moons; P Carmeliet; F J Castellino; D Collen; E D Rosen
Journal:  Thromb Haemost       Date:  2000-02       Impact factor: 5.249

6.  Molecular characterization of two novel mutations causing factor X deficiency in a Chinese pedigree.

Authors:  W-B Wang; Q-H Fu; R-F Zhou; W-M Wu; Q-L Ding; Y-Q Hu; X-F Wang; H-L Wang; Z-Y Wang
Journal:  Haemophilia       Date:  2005-01       Impact factor: 4.287

Review 7.  Unexplained discrepancies in the activity--antigen ratio in congenital FX deficiencies with defects in the catalytic domain.

Authors:  A Girolami; P Scarparo; S Vettore; N Candeo; R Scandellari; A M Lombardi
Journal:  Clin Appl Thromb Hemost       Date:  2009-08-09       Impact factor: 2.389

8.  Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency.

Authors:  Mirko Pinotti; Rodney M Camire; Marcello Baroni; Anna Rajab; Giovanna Marchetti; Francesco Bernardi
Journal:  Thromb Haemost       Date:  2003-02       Impact factor: 5.249

9.  The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.

Authors:  Qiulan Ding; Yiping Shen; Likui Yang; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

10.  A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X.

Authors:  S J Tai; R W Herzog; P Margaritis; V R Arruda; K Chu; J A Golden; P A Labosky; K A High
Journal:  J Thromb Haemost       Date:  2007-11-23       Impact factor: 5.824

View more
  1 in total

1.  Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree.

Authors:  Yuanzheng Feng; Jiewen Ma; Liang V Tang; Wenyi Lin; Yanyi Tao; Zhipeng Cheng; Yu Hu
Journal:  Genes (Basel)       Date:  2021-09-27       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.